Your browser doesn't support javascript.
loading
Structure-Activity Relationship Studies of the Natural Product Gq/11 Protein Inhibitor YM-254890.
Xiong, Xiao-Feng; Zhang, Hang; Boesgaard, Michael W; Underwood, Christina R; Bräuner-Osborne, Hans; Strømgaard, Kristian.
Afiliación
  • Xiong XF; Department of Drug Design and Pharmacology, University of Copenhagen, 2100, Copenhagen, Denmark.
  • Zhang H; School of Pharmaceutical Sciences, Sun Yat-sen University, Guangzhou, 510006, China.
  • Boesgaard MW; Department of Drug Design and Pharmacology, University of Copenhagen, 2100, Copenhagen, Denmark.
  • Underwood CR; Key Laboratory of Advanced Drug Preparation Technologies, Ministry of Education, Co-innovation Center of Henan Province for New Drug R&D and Preclinical Safety, School of Pharmaceutical Sciences, Zhengzhou University, 100 Kexue Avenue, Zhengzhou, Henan, 450001, China.
  • Bräuner-Osborne H; Department of Drug Design and Pharmacology, University of Copenhagen, 2100, Copenhagen, Denmark.
  • Strømgaard K; Department of Drug Design and Pharmacology, University of Copenhagen, 2100, Copenhagen, Denmark.
ChemMedChem ; 14(8): 865-870, 2019 04 17.
Article en En | MEDLINE | ID: mdl-30790465
ABSTRACT
G proteins act as molecular switches in G protein-coupled receptor signaling pathways and are key mediators for numerous important physiological processes. The natural product, cyclic depsipeptide YM-254890, together with the structurally similar FR900359, is the only known selective inhibitor of the Gq/11 subfamily of G proteins. We recently reported the first total synthesis of YM-254890 and FR900359, followed by synthesizing analogues to perform structure-activity relationship studies. However, incomplete information about their structure-activity relationship prevents the further development of potent and structurally simplified analogues. Herein we report the first systematic structure-activity relationship study toward the N-methyldehydroalanine moiety in YM-254890, by designing and synthesizing seven new analogues. Pharmacological characterization of the seven compounds for Gq/11 -, Gi/o - and Gs -mediated signaling showed that the simplified analogue YM-19 is the most potent Gq/11 inhibitor among the new analogues. This study provides information for the future design of potent and simplified YM-254890 analogues.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Péptidos Cíclicos / Productos Biológicos / Subunidades alfa de la Proteína de Unión al GTP Gq-G11 Límite: Animals Idioma: En Revista: ChemMedChem Asunto de la revista: FARMACOLOGIA / QUIMICA Año: 2019 Tipo del documento: Article País de afiliación: Dinamarca

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Péptidos Cíclicos / Productos Biológicos / Subunidades alfa de la Proteína de Unión al GTP Gq-G11 Límite: Animals Idioma: En Revista: ChemMedChem Asunto de la revista: FARMACOLOGIA / QUIMICA Año: 2019 Tipo del documento: Article País de afiliación: Dinamarca
...